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Background: METH is an illicit drug of abuse that influences gene expression in the rat striatum. Histone
modifications regulate gene transcription.
Methods: We therefore used microarray analysis and genome-scale approaches to examine potential relationships
between the effects of METH on gene expression and on DNA binding of histone H4 acetylated at lysine 4
(H4K5Ac) in the rat dorsal striatum of METH-naïve and METH-pretreated rats.
Results: Acute and chronic METH administration caused differential changes in striatal gene expression. METH also
increased H4K5Ac binding around the transcriptional start sites (TSSs) of genes in the rat striatum. In order to relate
gene expression to histone acetylation, we binned genes of similar expression into groups of 100 genes and
proceeded to relate gene expression to H4K5Ac binding. We found a positive correlation between gene expression
and H4K5Ac binding in the striatum of control rats. Similar correlations were observed in METH-treated rats. Genes
that showed acute METH-induced increased expression in saline-pretreated rats also showed METH-induced
increased H4K5Ac binding. The acute METH injection caused similar increases in H4K5Ac binding in METH-pretreated
rats, without affecting gene expression to the same degree. Finally, genes that showed METH-induced decreased
expression exhibited either decreases or no changes in H4K5Ac binding.
Conclusion: Acute METH injections caused increased gene expression of genes that showed increased H4K5Ac
binding near their transcription start sites.
Keywords: ChIP sequencing, Neural networks, Epigenetics, Histone acetylation, MicroarrayBackground
Methamphetamine (METH) is an illicit psychostimulant
that is abused throughout the world. The drug causes
behavioral abnormalities that include the development
of tolerance and dependence, paranoid states, and psych-
otic symptoms in human addicts [1,2]. In animals, METH
causes behavioral sensitization, is self-administered, and
causes structural plasticity in the brain [3-6]. The acute
behavioral effects of the drug are mediated by METH-* Correspondence: jcadet@intra.nida.nih.gov
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reproduction in any medium, provided the orinduced increases in the amount of dopamine (DA) re-
lease in brain synapses [7,8] and by subsequent stimula-
tion of DA receptors in various brain regions [9].
Activation of these receptors by direct or indirect agonists
such as cocaine and amphetamine induces acute changes
in the expression of several immediate early genes (IEGs)
in the striatum [10,11]. These observations have prompted
suggestions that the enduring behavioral and cognitive ef-
fects of these psychostimulants might be dependent on
transcriptional changes in the rat brain [12,13]. Similarly,
acute METH injections cause significant increases in the
expression of several IEGs in the rat brain [14 - 17]. These
genes include c-fos and Egr1, among others [9,16].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Cadet et al. BMC Genomics 2013, 14:545 Page 2 of 19
http://www.biomedcentral.com/1471-2164/14/545In contrast to the acute METH-induced transcrip-
tional changes, chronic METH administration produces
differential changes in IEG responses and blunts the ef-
fects of an acute single METH injection on the expres-
sion of several IEGs in the striatum [18]. These
observations had suggested that chronic METH expos-
ure might alter the molecular machinery that controls
the acute transcriptional effects of the drug. These
blunting effects might be consequent to alterations in
the complex interactions of factors that regulate gene
transcription [19,20]. During resting states, DNA is
compacted in ways that interfere with the binding of
transcription factors whereas DNA becomes more easily
accessible during activation of cells by various stimuli
[21-23]. DNA is indeed packaged into chromatin whose
fundamental subunit, the nucleosome, is made of 4 core
histones, histones H2A, H2B, H3, and H4 that form an
octomer (2 of each histone) surrounded by 146 bp of
DNA [24,25]. Biological processes are regulated, in part,
via post-translational modifications of these histones,
modifications that include acetylation, methylation,
phosphorylation, and ubiquitination [26-30]. Lysine resi-
dues of histone tails can be reversibly acetylated and
deacetylated by several histone acetyltransferases (HATs)
and histone deacetylases (HDACs), respectively [31-33]
and these modifications promote alterations in gene ex-
pression by enabling or inhibiting recruitment of regula-
tory factors onto DNA regulatory sequences [31,33,34].
In order to understand the relationship between
METH-induced changes in gene expression and histone
acetylation on a genome-wide scale, we used two un-
biased approaches, namely microarray analyses and
chromatin immunoprecipitation (ChIP) followed by
massive sequencing [35,36]. In the case of psycho-
stimulants including cocaine, investigators have focused
their studies, for the most part, on the effects of illicit
drugs on histone H3 modifications [37,38]. However, we
chose to investigate METH-induced changes on histone
H4 acetylated at lysine residue 5 (H4K5Ac) because a
strong link exists between gene activation and acetyl-
ation of lysine residues (K5, K8, K12, and K16) of his-
tone H4 [39-42]. We thus used ChIP-Seq to identify
sites of binding of H4K5Ac throughout the rat genome.
We found that H4K5Ac binding is ubiquitous in the rat
dorsal striatum and occurs mainly around transcription
start sites (TSSs). There was also a positive correlation
between global H4K5Ac binding and striatal gene ex-
pression. Moreover, acute METH-induced increases in
gene expression were associated with METH-induced
increased H4K5Ac binding on genes with increased ex-
pression in rats chronically pre-exposed to either saline
or METH. Thus, our results document a relationship be-
tween H4K5Ac binding and increased gene expression
on a global scale.Results
Acute and chronic METH administration causes
differential changes in striatal gene expression
We used microarray analysis (RatRef-12 Expression
BeadChips arrays, 22, 523 probes, obtained from
Illumina Inc., San Diego, CA) to provide a panoramic
view of the effects of METH on gene expression in rats
chronically exposed to either saline or METH. Using the
data obtained from these analyses, we sought to identify
molecular and cellular functions of genes with the
highest baseline expression in the striatum of control
rats. Towards that end, we picked the top 10 percent of
genes with the highest expression and ran them through
Ingenuity pathway Analysis (IPA). We found that these
genes were involved in nucleic acid metabolism (126
genes), post-translational modifications (72 genes), pro-
tein folding (26 genes), and cell death and survival (525
genes). They also participate in nervous system develop-
ment and function (303 genes), mediation of behaviors
(166 genes), as well as neurological (447 genes) and psy-
chological (181 genes) diseases. Top canonical pathways
include genes involved in mitochondrial functions, EIF2
signaling, protein ubiquitination, mTOR signaling, CDK5
signaling, dopamine-DARPP32 feedback in cAMP signal-
ing, NRF2-mediated oxidative stress response, and synap-
tic long-term potentiation. The high number of genes
involved in these pathways is consistent with the role of
dopamine in the striatum [43] and the energy demand
and production during brain functions, as well as the role
of mitochondrial dysfunction in neurodegenerative disor-
ders [44]. The high expression of these genes in this brain
structure supports the notion that the striatum is very
sensitive to mitochondrial oxidative dysfunctions [45].
Acute injection of METH (5 mg/kg) in METH-naïve
rats (SMvSS) caused significant changes in the expression
of 86 genes, with 60 being upregulated and 26 down-
regulated (Figure 1). IPA analysis revealed that these genes
are involved in the control of gene expression, participate
in cell signaling, regulate cellular growth and proliferation,
control organ morphology, and participates in the mani-
festation of behaviors. Figure 2 shows networks of genes
that are involved in the control of gene expression, cellular
compromise, and endocrine system development. Upregu-
lated genes found in these networks include several tran-
scription factors, namely Arc, c-fos, Crem, Egr1, Egr2,
Egr4, c-fos, junB, Npas4, Nptx2, Nr4a3 (NOR-1) (Figure 2
and Additional file 1: Table S3). The expression of some of
these is known to be influenced by illicit drugs, including
cocaine [46] and METH [9,14]. Other genes of interests
include Dusp14, neurotensin, and orexin-A (hypocretin,
HCRT) that are also upregulated (Additional file 1: Table S3).
Top canonical pathways that involve these genes include
GADD45 signaling, TGFbeta signaling, acute phase re-
sponse signaling, and NRF2-mediated oxidative stress.
Figure 1 Microarray analysis identifies selective groups of genes
that are differentially expressed after an acute METH injection into
METH-naive and METH-pretreated rats. The Venn diagram shows
the overlap of the effects of METH on gene expression. Genes were
identified as altered by METH if they showed greater than + 1.7-fold
changes (p < 0.01) in mRNA levels in the array experiments. Only 6
genes show overlap between the SM and MM groups. The full list of
the METH-regulated genes is given in Additional file 1: Tables S3 and S4.
Figure 2 Pathway analysis of METH-regulated genes in METH-
naïve rats. METH caused changes in the expression of genes involved
(A) in the control of gene expression and cellular compromise and
(B) in the regulation of endocrine system development and functions.
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pretreated rats (MMvSS) caused significant alterations in
the expression of 71 genes, with only 18 being upregu-
lated and 53 being downregulated. The list of genes that
were affected by the acute METH administration to the
chronically METH-treated rats are shown in Additional
file 1: Table S4. These genes are involved in cellular de-
velopment, cell-to-cell signaling and interaction, and
carbohydrate metabolism. Top canonical pathways in-
clude glioma invasiveness and Rac signaling. The list of
genes includes Npb and Nr4a3 that are upregulated and
BMP2 that is downregulated by the acute METH injec-
tion to rats pre-exposed to the drug. Figure 3 shows net-
works of genes that are involved in cell cycle, drug
metabolism, tissue development, and reproductive sys-
tem development and function. Figure 4 shows quantita-
tive PCR validation of the METH-induced changes in
the expression of some genes of interest in METH-naïve
and METH-pretreated rats. These are DnajB5, Egr1,
Nptx2, Nts, and Npb.
Genome-wide analysis of H4K5Ac binding in the rat
striatum after METH exposure
Although we have consistently shown that acute admin-
istration of various doses of METH can cause substantial
alterations in gene expression [14-16,47], the epigeneticevents involved in these changes have yet to be charac-
terized. Gene expression in the central nervous system is
regulated, in part, by epigenetic alterations that include
post-translational modifications of histone tails including
histone acetylation and methylation [48]. Changes in
large-scale DNA binding by modified histones and other
proteins, after various manipulations, are now being
Figure 3 Pathway analysis of METH-regulated genes in METH-
pretreated rats. METH caused changes in the expression of genes
that participate (A) in cell cycle and drug metabolism and (B) in
reproductive system development and function.
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that a similar approach might help us to identify epigen-
etic alterations that participate in the acute effects of
METH on gene expression in the rat dorsal striatum of
METH-naïve and METH-pretreated rats. As shown in
Figure 5, genome-wide analysis of H4K5AC bindingreveals that H4K5Ac binds around the transcription start
sites (TSSs) of genes in the control (Figure 5A), SM
(Figure 5B), MS (Figure 5C), and in the MM (Figure 5D)
groups. However, there were additional H4K5Ac binding
sites in the SM (87,089 H4K5Ac binding sites corre-
sponding to 10,463 annotated genes), MS (50,031 bind-
ing sites, 9,877 genes), and the MM (74,856 binding
sites, 10,301 genes) groups in comparison to the control
animals that showed 22,262 H4K5Ac binding sites corre-
sponding to 8,203 annotated genes in the rat striatum
(Figure 6). The majority of genes with H4K5Ac binding
in the SS group were also found in the SM, MS, and
MM groups (Figure 6). As shown in the figure, 99% of
the genes with H4K5Ac binding sites in the control rats
(SS) were also found in the METH-naïve rats that re-
ceived an acute METH injection. Similarly, the majority
(97%) of the genes with H4K5Ac binding sites in the
control rats were also found in the chronic METH-
treated groups, while 99% of the genes in the control
group were also found in the MM group. Taken to-
gether, these data suggest that both acute and chronic
treatment with METH caused the appearance of de novo
H4K5Ac binding sites in a large number of genes that
are expressed in the striatum. Figure 6A also reveals that
the vast majority of genes with H4K5Ac binding sites in
the groups that had received either acute or chronic
METH treatments were co-localized: 9,731 genes in SM
and MS, 9,643 genes in MS and MM, 10,090 genes in
SM and MM, and 9,543 genes in the 3 METH groups.
Figure 6B also shows the majority of METH-induced
additional H4K5Ac binding sites were located on genes
that were commonly found (1627 annotated genes) in the
3 METH groups. In addition, 1776 genes were common
in the SM and MS groups, 1996 genes in the SM and MM
groups, and 1683 genes in the MS and MM groups. These
results indicate that METH administration exerts consist-
ent effects on H4K5Ac binding in the rodent brain.
Pathway analyses revealed that genes with novel
H4K5Ac binding in the SM group are involved in pro-
tein synthesis (93 genes), cellular growth and prolifera-
tion (539 genes), cell death and survival (582 genes),
nervous system development and function (304 genes),
behaviors (188 genes), and neurological diseases (358
genes). Top canonical pathways include Ox40 signaling
pathway, acute phase response signaling, death receptor
signaling, and Huntington’s disease signaling. The genes
with novel H4K5Ac binding in the MM group participate
in the control of cell death and survival (552 genes), ner-
vous system development and function (264 genes), and
neurological diseases (356 genes). Top canonical pathways
included OX40 signaling, acute phase response signaling,
death receptor signaling, G-protein-coupled receptor sig-
naling, cAMP-mediated signaling, and Huntington Dis-


















































































Figure 4 Quantitative PCR confirmed the METH-induced changes in gene expression. Acute METH administration increased the expression
of (A) DnajB5, (B) Egr1, (D) Nptx2, and (E) Nts, but not (C) Npb in METH-naïve rats. In contrast, the acute METH injection caused increases in the
expression of (C) Npb and (E) Nts in the METH-pretreated rats, with the effects of acute METH on Nts expression being significantly attenuated in
the METH-pretreated rats.
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known effects of METH on neurotransmitters and their
receptors [9].
We next chose the top 10% of genes with highest
H4K5Ac binding in the SS, SM, and MM groups for fur-
ther pathway analyses because we thought that they might
potentially play important roles in the functions of the
striatum in the absence or presence of METH exposure.
IPA revealed that the top 10 percent of the genes with
high H4K5Ac binding in the SS group are involved in
neurological diseases (61 genes), cancer (58 genes), and
developmental disorders (32 genes). Molecular and cellu-
lar functions in which they participate include cell cycle
regulation (32 genes) and lipid metabolism (10 genes).
They are also involved in tissue development (44 genes)
and nervous system development and function (41 genes).
Top canonical pathways include cAMP-mediated signal-
ing, protein ubiquitination pathway, NRF2-mediated oxi-
dative stress, G-protein-coupled receptor signaling, and
tuna splicing. The top 10 percent of genes with high
H4K5Ac binding in the SM group are involved in neuro-
logical diseases (208 genes) and developmental disorders
(91 genes). They also participate in the control of cellular
assembly and organization (159 genes), nervous systemdevelopment and function (198 genes) and behavior (109
genes). Top canonical pathways include protein kinase A
signaling, G-protein-coupled receptor signaling, CDK5
signaling, ERK/MAPK signaling, axonal guidance signal-
ing, and Dopamine-DARPP32 feedback in cAMP signal-
ing. Finally, in the MM group, genes in the top 10 percent
of high H4K5Ac binding belong to genes that participate
in control of gene expression (188 genes), cellular function
and maintenance (209 genes), and cell morphology (207).
They are also involved in neurological diseases (216
genes), developmental disorders (103 genes), and in ner-
vous system development and function (227 genes). In
addition, top canonical pathways in the MM group in-
clude molecular mechanisms of cancer, Wnt/beta-catenin
signaling, Dopamine-DARPP32 feedback in cAMP signal-
ing, and in G-protein-coupled receptor signaling. To-
gether, these observations are consistent with the idea that
acute and chronic METH administration can influence
histone acetylation in the brain.
Global striatal gene expression levels correlate with
H4K5Ac binding
In order to test if H4K5Ac binding correlated with striatal
gene expression, we carried out regression analyses and
SS H4K5Ac and Input SM H4K5Ac and Input


















































































































































Figure 5 H4K5Ac binding occurs at the TSSs of genes. The figure shows the distribution of H4K5Ac binding in (A) control rats (SS), (B) METH-
naïve rats treated with an acute injection of METH (SM), (C) rats chronically exposed to METH and then treated acutely with saline (MS), and (D) rats
chronically exposed to METH and then given an acute injection of METH before being euthanized (MM). The pattern of H4K5Ac binding in the brain
was not influenced by neither acute nor chronic METH exposure.
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pared as described previously [51]. Figure 7 shows that
there were positive correlations between the levels of stri-
atal H4K5Ac binding and gene expression in the control
(Figure 7A), SM (Figure 7B), MS (Figure 7C), and MM
(Figure 7D) groups. These data obtained from the rat
brain provide further support for the notion that H4K5
acetylation is an important factor in gene transcription, as
reported previously using other models [39-41,52].
Acute METH-inducible genes are accompanied by
METH-induced increased H4K5Ac binding
As reported above, the acute METH injection caused in-
creased expression of 60 and decreased expression of 26
genes in METH-naïve rats (SM group). We thus wanted
to know if METH-induced increased H4K5Ac binding
might be related to increased gene expression caused by
the drug. Towards that end, we compared H4K5Ac
binding between the SS and SM groups among the genesthat showed acute changes after the METH injection.
We found that 29 of 32 annotated genes present in the
array and ChIP-Seq data showed acute METH-induced
increased gene expression and increased H4K5Ac bind-
ing, while the other 3 genes showed no changes (Table 1).
These genes include Arc, c-fos, Egr1, and Crem that are
known to be involved in the actions of psychostimulants,
including cocaine, in the brain [46,53-55]. Together,
these observations support a common role for these
genes in drug-induced neuroadaptations in the brain. In
contrast, 3 of the 5 down-regulated genes identified on
both platforms show no changes while 2 genes showed
decreased H4K5Ac binding (Table 1). IPA revealed that
the 29 genes with increased expression and H4K5Ac
binding are involved in the control of gene expression
(16 genes), cellular development (15 genes), cell death
and survival (18 genes), and organism development (17
genes). Top canonical pathways include GADD45 signal-
ing, TGF-beta signaling, NRF2-mediated oxidative stress
Genes with H4K5Ac binding per group 
A 
B 
Genes with  novel H4K5Ac binding 
Figure 6 ChIP-Seq analysis shows that methamphetamine
caused large-scale increased H4K5Ac binding in the rat
striatum. The Venn diagram in (A) shows the overlap of the effects
of acute and chronic METH administration on H4K5Ac binding in
the four experimental groups: SS, SM, MS, and MM groups. The Venn
diagram in (B) shows additional H4K5Ac binding sites in the groups
treated with METH in comparison with the control (SS) group.
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networks of genes that are involved in embryonic devel-
opment and cellular compromise (Figure 8A), and in the
control of nervous system development and behavior
(Figure 8B).
Quantitative PCR confirmed the changes in gene ex-
pression after acute administration of the drug. Acute
METH causes significant increases in the expression of
Arc (3-fold, p < 0.0001) (Figure 9A), Crem (2.1-fold, p <0.0001) (Figure 9C), Egr2 (8.5-fold, p < 0.0001) (Figure 9E),
c-fos (7-fold, p < 0.0001) (Figure 9G), and Npas4 (4.4-fold,
p <0.0001) (Figure 9I) in saline pre-treated rats. In
METH-pretreated rats, acute METH also caused smaller
increases in Arc (1.8-fold, p = 0.034) (Figure 9A), Egr2
(5.9-fold, p < 0.001) (Figure 9E), c-fos, (3-fold, p = 0.0027)
(Figure 9G) but not in Crem (Figure 9C). In contrast,
Npas4 showed similar increases in saline- and METH-
pretreated (4.5-fold, p < 0.0001) (compare SM to MM
groups in Figure 9I) mRNA levels after the acute METH
injection. Interestingly, we found significant increases in
Arc, Egr2, and c-fos mRNA by quantitative PCR but not
on the microarray analyses. These observations are prob-
ably due to the stringent criteria that we used in the
microarray and the more quantitative nature of the PCR
analyses.
ChIP-PCR confirmed the ChIP-Seq data and showed
that acute METH caused significant increases in
H4K5ac binding around the TSSs of Arc (1.5-fold, p =
0.029) (Figure 9B), Crem (1.4-fold, p = 0.023) (Figure 9D),
Egr2 (1.6-fold, p = 0.015) (Figure 9F), c-fos (1.8-fold, p =
0.0021) (Figure 9H), and Npas4 (1.7-fold, p = 0.012)
(Figure 9J) in saline-pretreated rats. In contrast, there
was METH-induced increased H4K5Ac binding in the
METH-pretreated rats only around the TSSs of Egr2
(1.5-fold, p = 0.040) (Figure 9F) and Npas4 (1-6-fold,
p = 0.0013) (Figure 9J).
We also measured the protein expression of Arc and
c-fos (Figure 10). Acute METH caused significant in-
creases in Arc (3.67-fold, p = 0.0003) (Figure 10A) and
c-fos (3.31-fold, p = 0.0008) (Figure 10B) expression in
saline-pretreated rats. Repeated exposure to METH also
caused increased Arc (3.7-fold, p = 0.0003) and c-fos
(2.72-fold, p = 0.0049) protein expression. Moreover,
there were significant increases in Arc (3.04-fold, p =
0.0017) and c-fos (3.76-fold, p = 0.0003) protein expres-
sion in the MM group.
As reported above, the acute administration of METH
to METH-pretreated rats caused changes in the expres-
sion of 71 genes, with most genes being downregulated
(Figure 1). Table 2 shows that 4 of the 5 upregulated
genes identified on both platforms showed increased
H4K5Ac binding whereas one gene showed no changes
in binding. These genes included Npb and Nr4a3. IPA
shows that they are involved in cellular development
(Nr4a3), cell morphology (Gpr143), tissue development
(Nr4a3 and Gpr143), hereditary disorders (Gpr143 and
Ppef2), and reproductive system development and func-
tion (Npb). Figure 11A shows that these genes are in-
volved in networks that participate in carbohydrate and
lipid metabolism. In contrast, 7 of the 14 downregulated
annotated genes identified on both platforms showed no
changes while the other 7 showed decreased H4K5Ac
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Figure 7 H4K5Ac binding positively correlates with gene expression in the rat dorsal striatum. ChIP-Seq and expression data were
compared as described previously [51]. In short, genes were sorted based on gene expression values (Z scores) and binned into groups of 100
genes. The average gene expression value for each bin was then calculated. H4K5Ac tags were assigned to the nearest promoter region of genes
and normalized to the total tag counts for that sample. The mean tag counts of the above mention bins were also calculated. The averaged
binned gene expression values were then graphed against mean tag counts for each bin. The values in the insets represent the regression
coefficients (R2).
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the SM (6.4-fold, p < 0.0001) and MM (9.3-fold, p <
0.0001) groups (Figure 11B). ChIP-PCR also confirmed
the changes in H4K5Ac binding in the SM (2-fold, p =
0.0004) and MM (1.7-fold, p = 0.011) groups (Figure 11C).
Discussion and conclusion
Our study provides, for the first time, a comprehensive
map of acetylated H5K5Ac binding throughout the rat
genome and documents the presence of thousands of
these sites in genes expressed in the rat striatum. We
also show that H4K5Ac binding occurs around TSSs
and that the pattern of binding is not affected by METH
treatments. In addition, both acute and chronic METH
administration caused significant changes in H4K5Ac
binding, with additional binding sites being observed in
more genes after the acute METH injections. Moreover,
levels of gene expression correlated with genome-wide
H4K5Ac binding in the striatum. The microarrayanalysis further revealed that acute METH also caused
increased expression of 60 of 86 genes in saline-
pretreated rats whereas there was mostly decreased gene
expression (53 of 71 genes) after an acute METH injec-
tion to METH-pretreated rats. Important, the vast ma-
jority of genes with increased expression also
experienced increased H4K5Ac binding while the genes
with decreased expression showed either decreases or
no changes in H4K5Ac binding. The findings that
METH-induced increased H4K5Ac binding is associated
with increased expression of a set of genes after the
acute METH injection in METH-naïve rats is consistent
with the report that all-trans-retinoic acid caused in-
creased histone H4 acetylation and increased gene
expression during leukemic cell differentiation [56].
Our data are also consistent with the observation
that deletion of the histone deacetylase, RPD3, pro-
duced increased H4K5Ac binding at promoters of sev-
eral genes in Saccharomyces cerevisiae [41]. Nevertheless,
Table 1 Effects of acute METH injection on gene expression and H4K5Ac binding in METH-naïve rats
Symbol Definition FC H4K5Ac binding
Dusp14 Dual specificity phosphatase 14 13.17 4.35
Peli1 Pellino homolog 1 (Drosophila) 10.64 4.97
Npas4 Neuronal PAS domain protein 4 9.04 3.97
Prodh2 Proline dehydrogenase (oxidase) 2 6.95 4.24
Olr464 Olfactory receptor 464 6.51 3.71
Nr4a3 Nuclear receptor subfamily 4, group A, member 3 6.43 6.01
Fos FBJ murine osteosarcoma viral oncogene homolog 6.18 4.77
Nr4a3 Nuclear receptor subfamily 4, group A, member 3 4.71 4.39
Egr4 Early growth response 4 4.62 *
Fzd7 Frizzled homolog 7 (Drosophila) 4.22 *
Pkp2 Plakophilin 2 3.79 NC
Nptx2 Neuronal pentraxin II 3.77 2.44
Inhba Inhibin beta-A 3.71 *
Dhrs9 Dehydrogenase/reductase (SDR family) member 9 3.54 NC
Hcrt Hypocretin 3.08 3.07
Egr2 Early growth response 2 3.08 3.49
Arc Activity regulated cytoskeletal-associated protein 2.88 NC
Junb Jun-B oncogene 2.36 *
Taar8c Trace-amine-associated receptor 8c 2.33 *
Nts Neurotensin 2.32 2.67
Gadd45g Growth arrest and DNA-damage-inducible 45 gamma 2.21 5.30
Dnajb5 DnaJ (Hsp40) homolog, subfamily B, member 5 2.03 2.28
Cebpb CCAAT/enhancer binding protein (C/EBP) 1.99 2.75
Tgfb3 Transforming growth factor, beta 3 1.98 6.55
Egr1 Early growth response 1 1.89 *
Baz1a Bromodomain adjacent to zinc finger domain, 1A 1.89 3.13
Dusp5 Dual specificity phosphatase 5 1.84 *
Porf1 Preoptic regulatory factor 1 1.83 2.48
Per1 Period homolog 1 (Drosophila) 1.83 3.48
Ptpdc1 Protein tyrosine phosphatase domain containing 1. 1.82 4.24
Mchr1 Melanin-concentrating hormone receptor 1 1.81 3.79
Gpd1 Glycerol-3-phosphate dehydrogenase 1 (soluble). 1.80 3.70
Abcc10 ATP-binding cassette, sub-family C (CFTR/MRP) 1.78 5.25
Crem cAMP responsive element modulator 1.77 3.34
Mafk v-maf musculoaponeurotic fibrosarcoma oncogene family 1.77 3.21
Vgf VGF nerve growth factor inducible 1.76 3.67
Sstr4 Somatostatin receptor 4 1.75 3.86
Gadd45b Growth arrest and DNA-damage-inducible 45 beta 1.72 3.26
Snf1lk SNF1-like kinase 1.72 3.07
Asb1 Ankyrin repeat and SOCS box-containing protein 1 1.71 *
Pip3ap Phosphatidylinositol-3-phosphatase associated protein 1.70 *
Stag3 Stromal antigen 3 −1.85 *
Gpr149 G protein-coupled receptor 149 −1.85 NC
Vegfc Vascular endothelial growth factor C −1.90 −1.49
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Table 1 Effects of acute METH injection on gene expression and H4K5Ac binding in METH-naïve rats (Continued)
Jag1 Jagged 1 (Jag1), mRNA. −1.94 −3.50
Olr990 Olfactory receptor 990 (Olr990), mRNA. −4.34 *
Amy1 Amylase 1, salivary (Amy1), mRNA. −4.54 *
Tshr Thyroid stimulating hormone receptor (Tshr), mRNA. −4.85 *
Dao1 D-amino acid oxidase 1 (Dao1), mRNA. −4.94 NC
Plg Plasminogen (Plg), mRNA. −5.37 *
Olr1463 Olfactory receptor 1463 (Olr1463), mRNA. −5.61 NC
Olr462 Olfactory receptor 462 (Olr462), mRNA. −5.87 *
Fshr Follicle stimulating hormone receptor (Fshr), mRNA. −6.06 *
Gene expression was measured by microarray analysis. Genes were identified as showing changes in expression if they showed greater than ±1.7-fold changes
(p < 0.01) in comparison to the control group. H4K5Ac binding was measured by ChIP-Seq assays. H4K5Ac binding was calculated by comparing the control and
METH-treated groups, after corrections for DNA inputs. Abbreviations: FC fold changes, NC no changes in H4K5Ac binding, *, no H4K5Ac binding sites observed.
Cadet et al. BMC Genomics 2013, 14:545 Page 10 of 19
http://www.biomedcentral.com/1471-2164/14/545the relationship of METH-induced increased H4K5Ac
binding to increase gene expression appears to be some-
what complex. For example, METH-induced increased
H4K5Ac binding in the SM or MM groups did not neces-
sarily translate into significant METH-induced changes in
gene expression as measured by the microarray analysis.
This conclusion is consistent with those of other investiga-
tors who have reported that individual activators can cause
differential patterns of histone acetylation, with some
causing increased H4 acetylation but others causing vari-
able effects on H4 acetylation and gene expression [57].
Together, these results suggest that, under the chronic
METH condition, METH-induced increased H4K5Ac
binding is not sufficient to cause METH-induced in-
creased expression of the majority of genes in the dorsal
striatum. These data implicate the existence of other epi-
genetic factors that might serve to regulate, in conjunction
with H4K5Ac binding, the expression of genes that show
substantial changes in H4K5Ac binding. This discussion
provides a partial explanation for our observation that the
acute METH injection caused mostly downregulation of
gene expression in the METH-pretreated rats. When
taken together with the observations of the existence of
epigenetic ensembles that control gene expression in hu-
man cells [50,58], our results suggest that combinatorial
epigenetic influences [21] might also be responsible for
the acute transcriptional changes observed after an acute
METH injection to METH-naïve or METH-pretreated
rats, with H4K5Ac binding playing a contributory role.
We also used qRT-PCR and ChIP-PCR in order to
confirm some of the changes observed using the two
discovery platforms. We picked Arc, Crem, Egr2, and
Nr4a3 because they are implicated in synaptic plasticity
[59-62]. Crem mRNA expression was increased in com-
parison to the control group only after the acute METH
injection to METH-naive rats. H4K5Ac binding around
Crem TSS was also increased after the acute METH ad-
ministration in METH-naïve rats but not in METH-
pretreated rats. These observations suggest that chronicMETH might have caused additional epigenetic modifi-
cations that had rendered Crem expression refractory to
the acute effects of the drug. These observations are
somewhat dissimilar to our observations of the effects of
METH on Egr2 expression. Specifically, the acute
METH injection caused substantial increases in Egr2
mRNA in saline-pretreated rats. In contrast, there was
attenuation of the acute METH-induced effects on Egr2
expression in the METH-pretreated rats. This attenu-
ation occurred in spite of the fact that acute METH
caused increased H4K5Ac binding in both METH-naive
and METH-pretreated rats. Egr2 is a member of the
Kruppel-like zinc finger transcription factors that in-
clude Egr1, Egr3 and Egr4 [62,63]. The Egrs are acti-
vated by neuronal activity [62,63] and by METH [14,15].
Egr2 mediates stabilization and maintenance of long-
term potentiation (LTP) [64] and regulates attentional
processes [65]. Although the role of Egr2 induced by
small METH doses is not clear, high METH doses have
been shown to cause Egr-dependent activation of Fas lig-
and (FasL)-mediated neuronal apoptosis [15]. Import-
antly, the observations that chronic METH pretreatment
blunted the acute effects of METH on Crem and Egr2
expression are consistent with data from other investiga-
tors who had reported that the acute effects of psycho-
stimulants on IEG expression were blunted in animals
previously exposed to either cocaine [46]or the amphet-
amines [18,66,67]. Altogether, the observation of chronic
drug administration-induced blunting effects of the
acute transcriptional consequences of psychostimulants
suggests that these phenomena might participate in mo-
lecular events responsible for drug-induced tolerance
[68]. They might also explain, in part, the need for re-
peated drug-seeking and drug-taking behaviors that are
sine qua non of drug addiction [69,70].
It is also of interest to discuss the effects of acute and
chronic effects of METH on Nr4a3 expression in con-
trast to the observations with Crem and Egr2 discussed
above. Nr4a3 is a member of Nr4a1/Nur77 family of
Figure 8 Acute METH induces increases in gene expression and
H4K5ac binding at the TSS of genes involved in embryonic
development, behavior, and nervous system development in
METH-naïve rats. (A) IPA of genes involved embryonic development
and (B) IPA of genes that control behaviors and nervous system
development.
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Nurr1 and Nr4a3/Nor-1) that belong the superfamily of
steroid nuclear hormone receptor superfamily [71,72].
They participate in a number of biological functions in-
cluding cellular proliferation, differentiation, and apop-
tosis [71,72]. Nr4a3 also regulates axonal guidance and
pyramidal cell survival in the hippocampus [73]. As
shown above, PCR assays confirmed both the METH-induced changes in Nr4a3 gene expression and in
H4K5Ac binding that were identified by the microarray
and ChIP-Seq experiments, respectively. Importantly, we
found that chronic METH did not produce blunting of the
acute METH-induced increased in Nr4a3 expression in the
METH-pretreated rats in contrast to the observations for
Crem and Egr2 mRNA expression discussed above. When
taken together, our observations hint to a role of these
genes as important yet differential regulators of molecular
events that are consequent to repeated METH exposure.
In addition to the IEGs, acute METH was found to in-
crease neurotensin mRNA levels and H4K5Ac binding
around the Nts TSS in the striatum. We also found that
the acute effects of METH on Nts expression were
somewhat attenuated in METH-pretreated rats. This is of
interest because acute METH administration is known to
cause increased neurotensin mRNA and protein expres-
sion in the rat striatum [74-76]. Similar increases are also
observed in animals trained to self-administer the drug
[6,77,78]. Our observations thus add to the literature that
indicates that METH influences this neuropeptidergic sys-
tem in the rat brain. It is important to note that a recent
study had reported that neurotensin levels are significantly
downregulated in the striatum of rats that had undergone
extinction training after METH self-administration [79],
suggesting differential responses in neurotensin expression
after acute METH and during drug withdrawal. In any
case, when taken together, these observations suggest that
neurotensin might play an important role in the acute be-
havioral responses to the drug and/or in the maintenance
of METH self-administration. The demonstration that
METH also increased H4K5Ac binding at the Nts gene
promoter provides a partial explanation for the acute ef-
fects of the drug on neurotensin expression in the striatum.
Another peptide of interest is neuropeptide B (NPB)
that also shows increased mRNA expression after
chronic METH treatments. NPB, a neuropeptide of 29
aa residues, was identified as an endogenous ligand for
the G protein-coupled receptor, GPR7, whose stimula-
tion causes decreased intracellular cAMP production
[80,81]. The NPB transcript is widely distributed in the
brain [81,82]. NPB has been implicated in the regulation
of pain sensation, endocrine function, as well as feeding
behaviors [81,83-86]. For example, intracerebral NPB in-
jection decreases feeding behaviors [81] whereas NPB-
knockout mice are obese [85]. These observations are
compatible with the known anorectic effects of the am-
phetamine analogs including METH [87,88] and suggest
that NPB might play a role in METH-induced chronic
anorexia. The veracity of this argument will need to be
tested experimentally. The role of NPB in other behav-
ioral aspects of METH needs also to be considered. In
any case, the present observations add to the growing
literature that METH can substantially influence the
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Figure 9 Real-time PCR validation of the changes of expression
and in H4K5Ac binding observed in genes of interest. Quantitative
PCR shows that acute METH induced significant increases in the
expression of (A) Arc, (C) Crem, (E) Egr2, (G) c-fos, and (I) Npas4 in
saline pre-treated rats. Acute METH also caused smaller increases in
(A) Arc, (E) Egr2, (G) c-fos, expression in METH-pretreated rats. In
contrast, acute METH produced similar increases in (I) Npas4
expression in both saline- and METH-pretreated animals. The figure
also shows the results of ChIP-PCR that revealed acute METH-
induced increases in H4K5ac binding around the TSSs of (B) Arc,
(D) Crem, (F) Egr2, (H) c-fos, and (J) Npas4 in saline-pretreated rats.
METH-induced increased H4K5Ac binding in the METH-pretreated
rats was observed only around the TSSs of (F) Egr2 and (J) Npas4.
The data represent means ± SEM of 5–8 animals per group. Statistical
analyses are described in the text. *, **, *** = p < 0.05, 0.001, 0.001,
respectively, in comparison to the SS group; #, ##, ### = p < 0.05, 0.01,
0.001, respectively in comparison to the SM group; !, !!, !!! = p < 0.05,
0.01, 0.001, respectively in comparison to the MS group.
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substances in the acute and long-term neuroplastic ef-
fects of the drug.
It is also of interest to discuss some of the METH-
induced networks that were identified by pathway ana-
lysis. The IPA showed that injections of METH induced
the expression of genes that are involved in the develop-
ment of diverse systems. These genes include Egr1, Egr2,
c-fos, Nr4a3, and Vgf (Figures 2, 3 and 8). The METH-
induced increased expression of the developmental gene,
foxa3 (Figure 3) which is a member of the family of
forkhead winged transcription factors [89,90], is of inter-
est because, together with the changes in other tran-
scription factors, these observations support the notion
that amphetamine and its analogs might recapitulate de-
velopmental programs in adult animals [91]. This idea
was initially based on the findings of Webb et al. (2009)
[92] who had reported that, in zebrafish, amphetamine
induced a set of genes enriched with transcription fac-
tors that are known to participate in developmental pro-
cesses. Our observations are also consistent with the
idea that drug addiction is dependent on altered synaptic
plasticity [93-96] that are regulated, in part, by develop-
mental factors in adult animals [91,97].
In summary, our study has provided a detailed de-
scription of the acute and chronic effects of METH on
H4K5Ac binding and gene expression in the brain. We
found that acute METH-induced increases in H4K5Ac
binding were, in part, responsible for a subset of METH-
upregulated genes in METH-naïve and METH-pretreated
rats. However, given the appearance of many novel
H4K5Ac binding sites in the striatum after both acute and
chronic METH administration, the observations of
METH-induced changes in the expression of only a few
genes suggest that the presence of METH-induced novel
H4K5Ac binding sites might be necessary but not suffi-



































Figure 10 METH administration caused increased Arc (A) and
c-fos (B) protein expression in the rat striatum. The data
represent means ±SEM of 5–8 animals per group. Statistical analyses
are described in the text. *, **, = p < 0.005, 0.001, respectively, in
comparison to the SS group.
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http://www.biomedcentral.com/1471-2164/14/545Moreover, because the acute METH injection caused,
for the most part, decreased mRNA levels in METH-
pre-exposed rats, the possibility exists that repeated
METH exposure might have triggered epigenetic
modifications which had negatively impacted the ex-
pression of METH-responsive genes. This idea is con-
sistent with the combinatorial nature of epigenetic
events that control inducible gene expression [21,50].
Finally, given the adverse neuropsychiatric and psy-
chosocial consequences of METH addiction, similar
studies are necessary to help to identify specific long-
lasting epigenetic effects of repeated METH exposure.
The elucidation of these molecular alterations might
help to develop alternative pharmacological ap-




Male Sprague–Dawley rats (Charles Rivers Laborator-
ies, Raleigh, NC), weighing 330–370 g in the begin-
ning of the experiment were used in the present
study. Animals were housed in a humidity- and
temperature-controlled room and were given free ac-
cess to food and water. All animal procedures were
performed according to the National Institutes of
Health Guide for the Care and Use of Laboratory An-
imals and were approved by the National Institute of
Drug Abuse-/ Intramural Research Program (IRP) Ani-
mal Care and Use Committee (NIDA/IRP-ACUC).
Drug treatment and tissue collection
Following habituation, rats were injected intraperito-
neally with either (±) METH-hydrochloride (NIDA,
Baltimore, MD) or an equivalent volume of 0.9% sa-
line over a period of two weeks as described in
Additional file 1: Table S1. The saline- or METH-
pretreated animals received a single injection of saline
or METH (5 mg/kg × 1) at 16–18 hrs after the last
saline or METH pretreatment injection. This dose of
METH does not cause any neurotoxic effects, as
much larger doses are required for pathological
changes to develop in the rodent brain [47]. The four
groups of animals were: saline/saline (SS), saline/
METH (SM), METH/saline (MS), and METH/METH
(MM). The animals were euthanized by decapitation
2 hrs later and their brains were quickly removed.
Table 2 Effects of acute METH injection on gene expression and H4K5Ac binding in METH-pretreated rats
Symbol Definition FC Binding
Olr577 Olfactory receptor 577 6.39 *
Npb Neuropeptide B 5.70 4.22
Plagl2 Pleiomorphic adenoma gene-like 2 4.67 *
Cpt1b Carnitine palmitoyltransferase 1b, muscle 3.91 *
Ppef2 Protein phosphatase, EF hand calcium-binding domain 3.07 2.95
Gpr143 G protein-coupled receptor 143 (Gpr143), mRNA. 2.88 4.88
Nr4a3 Nuclear receptor subfamily 4, group A, member 3 2.79 4.22
Foxa3 Forkhead box A3 2.60 NC
Olr734 Olfactory receptor 734 2.28 *
Olfml2a Olfactomedin-like 2A −1.71 NC
Zfp533 Zinc finger protein 533 −1.73 *
Pard3 Par-3 (partitioning defective 3) homolog (C. elegans) −1.74 −3.94
Tle4 Transducin-like enhancer of split 4, homolog of Drosophila E [20] −1.75 −4.22
Bcar3 Breast cancer anti-estrogen resistance 3 −1.76 −2.94
Plag1 Pleiomorphic adenoma gene 1 −1.76 *
Rcn1 Reticulocalbin 1 −1.81 *
Gpcr12 G-protein coupled receptor 12 −1.81 NC
Arl6 ADP-ribosylation factor-like 6 −1.87 NC
Prkcm Protein kinase C, mu −1.88 *
Clcn1 Chloride channel 1 −1.90 *
Jag1 Jagged 1 −1.94 −3.50
Fbxo15 F-box protein 15 −1.96 *
Bmp2 Bone morphogenetic protein 2 −1.99 −3.14
Cd44 CD44 antigen −2.01 *
Rims2 Regulating synaptic membrane exocytosis 2 −2.13 −3.50
Gpr149 G protein-coupled receptor 149 −2.14 −3.23
Spdya Speedy homolog A (Drosophila) −2.35 NC
Plin Perilipin −2.47 *
Stag3 Stromal antigen 3 −2.51 *
Clca3 Chloride channel calcium activated 3 −3.77 *
Cldn22 Claudin 22 −3.89 NC
Nek1 NIMA (never in mitosis gene a)-related expressed kinase 1 −4.36 NC
Olr990 Olfactory receptor 990 −4.50 *
Ctcfl CCCTC-binding factor (zinc finger protein)-like −5.45 *
Sdfr2 Stromal cell derived factor receptor 2 −6.02 *
Traf4af1 TRAF4 associated factor 1 −8.83 NC
Plg Plasminogen −9.93 *
Genes were identified and calculations were performed as described in Table 1. Abbreviations: FC fold changes, NC no changes in H4K5Ac binding, *, no H4K5Ac
binding sites observed.
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http://www.biomedcentral.com/1471-2164/14/545Striatal tissues from one side were dissected on ice,
snap frozen on dry ice, and stored at −80°C until
used in microarray and quantitative PCR experiments
whereas the other side was processed for ChIP exper-
iments detailed below.RNA extraction
Total RNA was isolated using Qiagen RNeasy Mini kit
(Qiagen, Valencia, CA) according to the manufacturer’s
instructions. RNA integrity was assessed using an
Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA) and
ANr4a3 mRNA
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Figure 11 METH produces increased expression and increased H4K5Ac binding in a small number of genes in METH-pretreated rats.
(A). METH increased gene expression and H4K5Ac binding in TSSs of genes involved in molecular transport and in carbohydrate and lipid
metabolism. Quantitative PCR was used to validate the results of the microarray (B) and ChIP-Seq (C) analyses. Statistical analyses are described in
the text. *, **, *** = p < 0.05, 0.001, 0.001, respectively, in comparison to the SS group; #, ##, ### = p < 0.05, 0.01, 0.001, respectively in
comparison to the SM group; !, !!, !!! = p < 0.05, 0.01, 0.001, respectively in comparison to the MS group.
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http://www.biomedcentral.com/1471-2164/14/545showed no degradation. The RNA extracted from the
striatum was used to measure gene expression by micro-
array analysis and quantitative PCR was used to confirm
the expression of some genes of interest.Microarray analysis
Microarray hybridization was carried out using RatRef-
12 Expression BeadChips arrays (22, 523 probes)
(Illumina Inc., San Diego, CA) essentially as previously
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GeneSpring and normalized using global normalization.
The normalized data were used to identify changes in
gene expression after the various patterns of METH in-
jections as described above. A gene was identified as sig-
nificantly affected if it showed increased or decreased
expression according to an arbitrary cut-off of 1.7-fold
change at p<0.01, according to the GeneSpring statistical
package. Similar criteria have been successfully used in
our previous microarray studies [15,16]. Network ana-
lyses were performed using the Ingenuity Pathway Ana-
lysis (IPA) software (Ingenuity Systems, Redwood City,
CA). The IPA software allows for the identification of
networks, canonical pathways, and biological functions
that are affected by the drug. We also used the IPA soft-
ware to graphically show the cellular location of genes
significantly affected by METH.
Quantification of mRNA by quantitative real-time PCR
Total RNA was obtained individually from 6–8 rats per
group and was reverse-transcribed with oligo dT primers
and RT for PCR kit (Clontech, Palo Alto, CA). PCR ex-
periments were done using the Chroma4 RT-PCR De-
tection System (BioRad Hercules, CA USA) and iQ
SYBR Green Supermix (BioRad) according to the manu-
facturer’s protocol. Sequences for gene-specific primers
corresponding to PCR targets were obtained using
LightCycler Probe Design software (Roche). The primers
were synthesized and HPLC-purified at the Synthesis
and Sequencing Facility of Johns Hopkins University
(Baltimore, MD). The sequences for the IEG primers
have been previously published [15,97]. Additional file 1:
Table S2 shows the sequences of the primers. Quantita-
tive PCR values were normalized using OAZ1 (ornithine
decarboxylase antizyme 1) based on a previous paper
[98]. The results are reported as relative changes calcu-
lated as the ratios of normalized gene expression data of
each group compared to the SS group. The list of
primers is noted in Additional file 1: Table S2.
ChIP-Seq and ChIP-PCR
Striatal tissues were processedfor ChIP-Seq and ChIP-
PCR. Briefly, brain tissues were minced to ~1 mm-sized
pieces, and immediatelycross-linked in 1% formaldehyde
for 15 min at room temperature. The tissues were
washed four times in cold PBS containing the proteinase
inhibitors in the Roche protease inhibitor cocktail tablet
(Roche Diagnostics) and 1 mMPMSF (Sigma). Tissues
were rapidly frozen on dry ice. The fixed tissues were
resuspendedin SDS lysis buffer (EMD Millipore Corp)
containing the Roche protease inhibitor cocktail and
1 mM PMSF and each sample was transferred to TPX
plastic tube (Diagenode Inc., Denville, NJ) and sonicated
~15 cycles of 30 sec Time ON and 30 sec Time OFFusing a Bioruptor (Diagenode Inc.). Fragmentation was
checked by gel analysis to confirm sheared ranges of 300-
600 bp. Dynabeads (Life Technologies, Grand Island, NY)
were incubated with 5 μg of a specific antibody directed
against H4K5Ac for ChIP-Seq. Similarly, samples from
another group of animals were incubated with the same
antibody to confirm some of the ChIP-Seq data using
ChIP-PCR. Sequences for the ChIP-PCR are shown in
Additional file 1: Table S2.
For DNA sequencing, adapters were ligated to the pre-
cipitated DNA fragments or the input DNA to construct
a sequencing library according to the manufacturer’s
protocol (Illumina, San Diego, CA). Sequencing images
generated were analyzed with the Firecrest program
followed by base calling using the Bustard program. The
first 41 bases were aligned to the rat reference genome
using the Gerald program. Firecrest, Bustard and Gerald
are part of the Illumina Analysis Pipeline package.
H4K5Ac binding was identified by ChIP-Seq and was
calculated by comparing the control and METH-treated
groups after corrections for DNA inputs. The microarray
and ChIP-Seq data have been deposited in NCBI under
GEO accession number GSE42776. ChIP-Seq and ex-
pression data were compared as described previously
[51]. In short, genes were sorted based on gene expres-
sion values (Z scores) and binned into groups of 100
genes. The average gene expression value for each bin
was then calculated. H4K5Ac tags were assigned to the
nearest promoter region of genes and normalized to the
total tag counts for that sample. The mean tag counts of
the above mention bins were also calculated. The aver-
aged binned gene expression values were then graphed
against mean tag counts for each bin.
Statistical analysis
Statistical analysis was performed using analysis of vari-
ance (ANOVA) followed by post-hoc analyses (StatView
4.02, SAS Institute, Cary, NC). Values are shown as means ±
SEM. The null hypothesis was rejected at p < 0.05.
Additional file
Additional file 1: These include Tables S1 to S4.
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